Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL01Antineoplastic agents
- Pharmacological subgroupL01XOther antineoplastic agents
- Chemical subgroupL01XK
- Chemical substanceL01XK02Niraparib
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Spain
AEMPS · 5 registrations
- Zejula 100 MG Comprimidos Recubiertos con Pelicula159,3 mg · comprimido recubierto con película · Glaxosmithkline Trading Services Limited
- Zejula 100 MG Capsulas Duras159.40 mg · cápsula dura · Glaxosmithkline Trading Services Limited
- Zejula 100 MG Comprimidos Recubiertos con Pelicula100 mg · comprimido recubierto con película · Glaxosmithkline Trading Services Limited
- Akeega 100 MG/500 MG Comprimidos Recubiertos con Pelicula159,40 mg + 500 mg · comprimido recubierto con película · Janssen-Cilag International N.V
Canada
Health Canada · 4 registrations
At a glance
- ATC code
- L01XK02
- Registers
- 10
- Registrations
- 27
- With their own page
- 27
- Companies
- 9
All medicines with Niraparib
Human medicines from every register that match Niraparib by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
27 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Zejula | United States | 100MG BASE, 200MG BASE, 300MG BASE | tablet | Marketed | Glaxosmithkline |
| Zejula | United States | 100MG BASE | capsule | Not marketed | Glaxosmithkline |
| AkeegaCombination | United States | 500MG; 100MG BASE, 500MG; 50MG BASE | tablet | Marketed | Janssen Biotech |
| AkeegaCombination | European Union | Authorised | Janssen-Cilag International N.V. | ||
| Akeega 100 MG/500 MG Comprimidos Recubiertos con PeliculaCombination | Spain | 159,40 mg + 500 mg | comprimido recubierto con película | Marketed | Janssen-Cilag International N.V |
| Akeega 50 MG/500 MG Comprimidos Recubiertos con PeliculaCombination | Spain | 79,70 mg + 500 mg | comprimido recubierto con película | Marketed | Janssen-Cilag International N.V |
| Zejula | European Union | Authorised | GlaxoSmithKline Trading Services Limited | ||
| Zejula 100 MG Comprimidos Recubiertos con Pelicula | Spain | 159,3 mg | comprimido recubierto con película | Marketed | Glaxosmithkline Trading Services Limited |
| Akeega 100 mg/500 mg filmomhulde tablettenCombination | Netherlands | Filmomhulde tablet | Authorised | Janssen-Cilag International NV | |
| Akeega 50 mg/500 mg filmomhulde tablettenCombination | Netherlands | Filmomhulde tablet | Authorised | Janssen-Cilag International NV | |
| Zejula 100 MG Capsulas Duras | Spain | 159.40 mg | cápsula dura | Authorised | Glaxosmithkline Trading Services Limited |
| Zejula 100 MG Comprimidos Recubiertos con Pelicula | Spain | 100 mg | comprimido recubierto con película | Authorised | Glaxosmithkline Trading Services Limited |
| Zejula 100 mg, filmomhulde tablet | Netherlands | Filmomhulde tablet | Authorised | GlaxoSmithKline Trading Services Limited | |
| Zejula 100 mg, harde capsules | Netherlands | Capsule, hard | Authorised | GlaxoSmithKline Trading Services Limited | |
| AkeegaCombination | Canada | 500 MG + 50 MG | Tablet | Marketed | Janssen INC |
| AkeegaCombination | Canada | 500 MG + 100 MG | Tablet | Marketed | Janssen INC |
| Zejula | Canada | 100 MG | Tablet | Marketed | Glaxosmithkline INC |
| AKEEGA Film Coated Tablets 100/500mgCombination | Taiwan | 膜衣錠 | Authorised | 嬌生股份有限公司 | |
| AKEEGA Film Coated Tablets 50/500mgCombination | Taiwan | 膜衣錠 | Authorised | 嬌生股份有限公司 | |
| Zejula | Brazil | Authorised | Glaxosmithkline Brasil Ltda | ||
| Zejula | Brazil | Authorised | Glaxosmithkline Brasil Ltda | ||
| Zejula Film-Coated Tablet 100MG | Singapore | 100mg | tablet, film coated | Authorised | Glaxosmithkline Pte LTD |
| Zejula Film-Coated Tablet 200MG | Singapore | 200mg | tablet, film coated | Authorised | Glaxosmithkline Pte LTD |
| AkeegaCombination | Croatia | Authorised | |||
| Zejula | Canada | 100 MG | Capsule | Not marketed | Glaxosmithkline INC |